Infection and drug resistance
Analysis of Plasma Biomarkers and Potential Pathogenesis in Children with Mycoplasma pneumoniae Pneumonia Based on Metabolomic Technology
By Xu Q, Shen L, Hong L and 3 others.
Abstract
Background
Mycoplasma pneumoniae pneumonia (MPP) is a common cause of community-acquired pneumonia in children, yet its metabolic alterations and pathogenic mechanisms remain incompletely understood. This study aimed to characterize the plasma metabolomic profile of children with MPP and explore associated metabolic pathways.
